← Browse by Condition
Medical Condition

lung cancer non small cell

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06405230 Phase 1, Phase 2
Recruiting

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Enrollment
40 pts
Location
United Kingdom
Sponsor
GlaxoSmithKline
View Trial →